
    
      Primary Purpose: Protocol designed to assess, by the use of long term non-invasive
      beat-to-beat monitoring with the SEEQ Mobile Cardiac Telemetry (MCT) system, the effect of
      BMS-919373 on the percent change from baseline relative to placebo of atrial fibrillation
      burden in subjects with paroxysmal atrial fibrillation.
    
  